Inhibrx Biosciences, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD for Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Inhibrx Biosciences, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate for Q2 2024.
  • Inhibrx Biosciences, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2024 was $98K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $98K Jun 30, 2024 10-Q 2024-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.